NUTRIEN LTD WKN: A2DWB8 ISIN: CA67077M1086 Kürzel: NTR Forum: Aktien Thema: Hauptdiskussion

Nutrien sees FY25 retail adjusted EBITDA $1.65B-$1.85B The company states: "Retail adjusted EBITDA guidance of $1.65B to $1.85B assumes higher crop nutrient sales volumes, continued growth of our proprietary products and further margin recovery in Brazil. We anticipate foreign exchange headwinds in our international retail operations and the absence of asset sales and other income items realized in 2024, which combined are estimated at approximately $75 million. Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with our global shipments outlook and accounts for some uncertainty regarding the possible imposition and related impact of US tariffs, as well as global supply availability. Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes continued reliability improvements and higher operating rates at our North American plants. Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production at our White Springs facility in the first half of 2025 and improved operating rates in the second half compared to the prior year. Total capital expenditures of $2.0 to $2.1 billion are expected to be lower than the prior year. Our capital expenditure program has been further optimized to sustain safe and reliable operations and to progress a set of targeted growth investments. This total includes approximately $400 to $500 million in investing capital expenditures focused on proprietary products, network optimization and digital capabilities in Retail, low-cost brownfield expansions in Nitrogen and mine automation projects in Potash."